• Home
  • About Us
  • Subscribe
  • Advertise
  • Newsroom
  • Sign In
  • Create Account
  • Sign Out
  • My Account
  • Current Issue
    • Latest News
    • Special Report
    • Up Close
    • Opinion
  • News by Sector
    • Real Estate & Construction
    • Banking & Finance
    • Health Care
    • Education & Talent
    • North Idaho
    • Technology
    • Manufacturing
    • Retail
    • Government
  • Roundups & Features
    • Calendar
    • People
    • Business Licenses
    • Q&A Profiles
    • Cranes & Elevators
    • Retrospective
    • Insights
    • Restaurants & Retail
  • Supplements & Magazines
    • Book of Lists
    • Building the INW
    • Market Fact Book
    • Economic Forecast
    • Best Places to Work
    • Partner Publications
  • E-Edition
  • Journal Events
    • Elevating the Conversation
    • Workforce Summit
    • Icons
    • Women in Leadership
    • Rising Stars
    • Best Places to Work
    • People of Influence
    • Business of the Year Awards
  • Podcasts
  • Sponsored
Home » Jubilant HollisterStier plans $70 million expansion

Jubilant HollisterStier plans $70 million expansion

Pharmaceutical maker expects to add 400 jobs while doubling space, capacity

December 22, 2020
Natasha Nellis

Spokane-based Jubilant HollisterStier LLC is planning to double its existing space and manufacturing capacity and add 400 employees during the next three years, says Amit Arora, president of the pharmaceutical manufacturing company.

The project, which will require an estimated $70 million investment by the company, will be funded internally and through loans from banks or other financial institutions, he says.

Jubilant HollisterStier manufactures and packages vaccines and therapeutics, from cancer drugs and related vaccines to antifungal injections.

The company currently is also manufacturing vaccines and therapeutics for COVID-19, says Arora.

The most well-known drug the company is manufacturing is therapeutic remdesivir, says Jack Wright, vice president of sales and marketing. Arora adds that the company is currently manufacturing four COVID-19 related products on site, though he declines to disclose specifics.

"We're working to expand more production for them in the coming months with some efficiency gains," says Wright. "But really what the long-term focus is, is we know COVID is looking to stay around with mutating strains, so we want to be able to handle the surge capacity."

Currently, the company has two manufacturing lines with the capacity to fill 110 million vials a year, Arora says. With the expansion, which will add a roughly 120,000-square-foot, two-story structure to its facilities at 3525 N. Regal, the company will be able to fill 220 million vials.

About 100,000 square feet will be for the two manufacturing lines the company plans to install, while roughly 20,000 square feet will be warehouse space.

The company plans to break ground within the next three months, and supplies for one of the new lines will be ordered within the next six weeks, he says. The two-phase expansion will be located next to the company's current manufacturing facility space on roughly 7 acres of land owned by the company.

Integrated Project Services LLC, a Pennsylvania-based pharmaceutical manufacturing consulting company, designed the expansion. A contractor hasn't been selected.

"We're looking at expanding our capacity by 50%," he says, adding, "Our plan is to double the capacity over the next three years from 110 million vials to 220 million vials, with 400 more jobs."

Those jobs will include a mix of degree-required quality positions and operations positions for which training will be provided onsite. There also will be project manager positions, which will require applicants to have certain certifications, says Arora.

Wright says, "We're expanding to increase our capacity first and foremost due to customer demand of existing customers, which includes the big pharmaceutical companies that we all have heard of in our households lately, as well as emerging biotech and the new therapies that are coming out requiring more sophisticated equipment and more technology than we currently have."

Wright adds that the expansion also will help meet expected continued demand for COVID-19 treatments and vaccines.

Currently, the company is running 24/7 to meet demand, a change that the company has made within the last 18 months and that Arora says will likely stick around.

Jubilant HollisterStier currently has 850 employees in Spokane. 

The company has experienced double-digit revenue growth over the last five years, and Arora says he expects that growth to continue.

The company currently serves 25 customers, primarily in North America, but also has clients in Europe and Asia, says Wright.

"Our customer mix is from big pharma to biotech-type companies working on monoclonal type antibodies for a few generic companies in our portfolio," says Wright.

Even if the demand for COVID-19 related products declines in the next year, the company has enough demand from existing customers to keep the company busy for the next two years, Arora says.

This is hardly the company's first foray into manufacturing drugs during a virus outbreak, adds Arora. The company, which will celebrate its 100th year next year, manufactured over 20 million vials, or 100 million doses, to treat the H1N1 virus in 2009.

"We've been a part of the vaccine world for the last 20 years," says Arora.

    Latest News Health Care Manufacturing
    • Related Articles

      Jubilant HollisterStier broadens its expansion plans in East Spokane

      Jubilant HollisterStier expansion moves ahead

      Jubilant HollisterStier plans to double capacity

    • Related Products

      Book of Lists - Digital Version - Health Care Plans

    Natasha Nellis

    2019 Rising Stars: Mary McDirmid

    More from this author
    Daily News Updates

    Subscribe today to our free E-Newsletters!

    SUBSCRIBE

    Featured Poll

    What is Spokane's most iconic historic building?

    Popular Articles

    • Stephanie vigil web
      By Karina Elias

      Catching up with: former news anchor Stephanie Vigil

    • 40.13 fc art
      By Tina Sulzle

      $165 million development planned at CDA National Reserve

    • Binw davebusters (72) web
      By Journal of Business Staff

      Dave & Buster's to open Spokane Valley venue in August

    • Stcu ceo lindseymyhre web
      By Journal of Business Staff

      STCU names new president, CEO

    • Centennial lofts
      By Erica Bullock

      Large Spokane Valley residential project advances

    • News Content
      • News
      • Special Report
      • Up Close
      • Roundups & Features
      • Opinion
    • More Content
      • E-Edition
      • E-Mail Newsletters
      • Newsroom
      • Special Publications
      • Partner Publications
    • Customer Service
      • Editorial Calendar
      • Our Readers
      • Advertising
      • Subscriptions
      • Media Kit
    • Other Links
      • About Us
      • Contact Us
      • Journal Events
      • Privacy Policy
      • Tri-Cities Publications

    Journal of Business BBB Business Review allianceLogo.jpg CVC_Logo-1_small.jpg

    All content copyright ©  2025 by the Journal of Business and Northwest Business Press Inc. All rights reserved.

    Design, CMS, Hosting & Web Development :: ePublishing